These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26691234)

  • 1. Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro.
    Kim S; Chung M; Jeon NL
    Biomaterials; 2016 Feb; 78():115-28. PubMed ID: 26691234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional
    Cho Y; Na K; Jun Y; Won J; Yang JH; Chung S
    Front Bioeng Biotechnol; 2021; 9():697657. PubMed ID: 34671596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary head and neck tumour-derived fibroblasts promote lymphangiogenesis in a lymphatic organotypic co-culture model.
    Lugo-Cintrón KM; Ayuso JM; Humayun M; Gong MM; Kerr SC; Ponik SM; Harari PM; Virumbrales-Muñoz M; Beebe DJ
    EBioMedicine; 2021 Nov; 73():103634. PubMed ID: 34673450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro.
    Nguyen DH; Stapleton SC; Yang MT; Cha SS; Choi CK; Galie PA; Chen CS
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6712-7. PubMed ID: 23569284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating lymphangiogenesis in a sacrificially bioprinted volumetric model of breast tumor tissue.
    Liu T; Liu Q; Anaya I; Huang D; Kong W; Mille LS; Zhang YS
    Methods; 2021 Jun; 190():72-79. PubMed ID: 32278014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling lymphangiogenesis: Pairing in vitro and in vivo metrics.
    Suarez AC; Hammel JH; Munson JM
    Microcirculation; 2023 Apr; 30(2-3):e12802. PubMed ID: 36760223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
    Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
    Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of lymphangiogenesis in development and cancer.
    Albrecht I; Christofori G
    Int J Dev Biol; 2011; 55(4-5):483-94. PubMed ID: 21858772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenic growth factors, receptors and therapies.
    Lohela M; Saaristo A; Veikkola T; Alitalo K
    Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphangiogenesis, inflammation and metastasis.
    Schoppmann SF
    Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Lived Human Lymphatic Endothelial Cells to Study Lymphatic Biology and Lymphatic Vessel/Tumor Coculture in a 3D Microfluidic Model.
    Frenkel N; Poghosyan S; Alarcón CR; García SB; Queiroz K; van den Bent L; Laoukili J; Rinkes IB; Vulto P; Kranenburg O; Hagendoorn J
    ACS Biomater Sci Eng; 2021 Jul; 7(7):3030-3042. PubMed ID: 34185991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis.
    Schulz MM; Reisen F; Zgraggen S; Fischer S; Yuen D; Kang GJ; Chen L; Schneider G; Detmar M
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):E2665-74. PubMed ID: 22949700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics.
    Ji RC
    Cancer Metastasis Rev; 2006 Dec; 25(4):677-94. PubMed ID: 17160713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets.
    Hu Z; Zhao X; Wu Z; Qu B; Yuan M; Xing Y; Song Y; Wang Z
    Signal Transduct Target Ther; 2024 Jan; 9(1):9. PubMed ID: 38172098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge.
    Achen MG; Stacker SA
    Int J Cancer; 2006 Oct; 119(8):1755-60. PubMed ID: 16557570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.